Eventide Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Eventide Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-1,212,000	Closed	-$40.3M	–	155
2020 Q2	$40.3M	Hold	1,212,000	–	–	0.88%	44
2020 Q1	$33M	Sell	1,212,000 -24,000	-2%	-$668K	1.07%	35
2019 Q4	$24.4M	Hold	1,236,000	–	–	0.69%	58
2019 Q3	$16M	Hold	1,236,000	–	–	0.53%	62
2019 Q2	$15.4M	Sell	1,236,000 -797,144	-39%	-$10.6M	0.47%	67
2019 Q1	$29.5M	Buy	2,033,144 +59,683	+3%	+$762K	1.02%	34
2018 Q4	$21.8M	Buy	1,973,461 +1,248,461	+172%	+$17.4M	0.96%	37
2018 Q3	$19.1M	Buy	725,000 +281,000	+63%	+$7.6M	0.7%	52
2018 Q2	$9.08M	Buy	444,000 +44,000	+11%	+$944K	0.38%	73
2018 Q1	$7.26M	Buy	+400,000	New	+$6.67M	0.34%	79

Other funds holding MNTA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Eventide Asset Management's MNTA Position: Q3 2020 in Review

Eventide Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 1,212,000 shares — an estimated $40.3M sold.

Eventide Asset Management first reported a position in MNTA in Q1 2018 and held it in 10 quarters. The position peaked at $40.3M in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

Eventide Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Eventide Asset Management sold 1,212,000 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $40.3M.
Eventide Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2018 and held it in 10 quarters.
Eventide Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $40.3M in Q2 2020.
211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Eventide Asset Management's 13F filing for Q3 2020, filed 13 Nov 2020.